Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Machine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares RepurchasedShares Repurchased
Ratios

PharmaCyte Biotech (PMCB) Preferred Shares Issued (2023)

PharmaCyte Biotech (PMCB) has disclosed Preferred Shares Issued for 1 consecutive years, with -$1.3 million as the latest value for Q4 2023.

  • On a quarterly basis, Preferred Shares Issued changed N/A to -$1.3 million in Q4 2023 year-over-year; TTM through Jul 2024 was -$1.3 million, a 103.86% decrease, with the full-year FY2024 number at $33.7 million, changed N/A from a year prior.
  • Preferred Shares Issued was -$1.3 million for Q4 2023 at PharmaCyte Biotech, down from $35.0 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $35.0 million in Q3 2023 to a low of -$1.3 million in Q4 2023.